ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A polymeric nanoformulation improves the bioavailability and efficacy of sorafenib for hepatocellular carcinoma therapy

Chen, Yang; Li, Jia-Xian; Shu, Na; Zheng, Sui-Juan; Ma, Min; Zhao, Zhi-Bin; Cao, Zhi-Ting*; Zhou, Qi*; Du, Jin-Zhi*; Wang, Jun中山大学; 1
Biomaterials Science2021-4-7DOI: 10.1039/d0bm01881c
4被引9阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Sorafenib (sfb) is widely used in clinics for advanced HCC therapy. However, the therapeutic efficacy of sfb is suboptimal due to its poor water solubility, low bioavailability, and side effects. Here, we employed a clinically safe polymer poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-PLA) to prepare a nanoparticle (NP)-based sfb formulation (NP-sfb) and tested its antitumor effect in multiple HCC models. NP-sfb could achieve effective drug loading and remain stable under physiological conditions. NP-sfb could be taken up by HepG2, Hepa1-6, and H22 cells and could efficiently inhibit cell proliferation and/or promote cell apoptosis. In vivo studies indicated that NP-sfb showed significantly improved therapeutic efficacy compared with free-sfb at the same dose or even higher doses. Mechanistic studies demonstrated that NP-sfb not only inhibited tumor proliferation and angiogenesis but also stimulated the tumor microenvironment by reducing the infiltration of immunosuppressive myeloid cells and increasing the ratio of cytotoxic T cells. This study demonstrates that the NP-based formulation is a promising strategy to improve the clinical application of sfb.

相关
加载中…
  • Sorafenib-Based Drug Delivery Systems: Applications and Perspectives
    Wang, Lingyun*; Chen, Meihuan; Ran, Xueguang; Tang, Hao; Cao, DerongPolymers, 2023, 15(12): 2638.
  • Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy
    Huang, Linzhuo; Xu, Rui; Li, Weirong; Lv, Li; Lin, Chunhao; Yang, Xianzhu; Yao, Yandan; Saw, Phei Er*; Xu, Xiaoding*Acta Biomaterialia, 2023, 162: 98-109.被引 3
  • 2-Methoxyestradiol loaded mesoporous polydopamine nanoprobes for hypoxia alleviation and sorafenib synergistic treatment of hepatocellular carcinoma
    Wang, Peifeng; Du, Yang; Zhao, Xingyang; Hu, Yueyang; Zhou, Tianjun; Liang, Xiaolong*; Fang, Chihua*; Tian, Jie*MATERIALS & DESIGN, 2023, 232: 112137.
查看全部 →

发表信息

论文状态
公开发表
期刊
Biomaterials Science
发表日期
2021-04-07
卷期
第 9 卷, 第 7 期
页码
2508-2518
DOI
10.1039/d0bm01881c
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE

作者

  • C

    Chen, Yang (第一作者)

    1

  • L

    Li, Jia-Xian

    1

查看全部 10 位作者收起作者
  • S

    Shu, Na

  • Z

    Zheng, Sui-Juan

    1

  • M

    Ma, Min

    1

  • Z

    Zhao, Zhi-Bin

    1

  • C

    Cao, Zhi-Ting (通讯)

    china pharmaceut univ

  • Z

    Zhou, Qi (通讯)

    1 · sun yat sen univ

  • D

    Du, Jin-Zhi (通讯)

    1

  • W

    Wang, Jun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417